Par Drugs & Chemicals Ltd. NSE: PAR

Par Drugs & Chemicals Live Share Price Today, Share Analysis and Chart

Name: Par Drugs & Chemicals Ltd.: Is Infosys Ltd. worth buying?
Item: Par Drugs & Chemicals Ltd.
Rating: 2.597125
Author: Trendlyne DVM scores

Mid-range Performer

about

Par Drugs & Chemicals primarily engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets.

99.72 -1.76 (-1.73%)

55.87% Fall from 52W High

4,936

NSE Volume

NSE 16 Dec, 2025 9:33 AM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Medium Financial Strength

- / 100

Affordable Valuation

- / 100

Technically Neutral

45.3 / 100

Mid-range Performer These stocks may be affordable or expensive, based on their medium quality and mid-range technical score. However, their reasonable financials are successful in gathering some investor interest. View Similar Embed DVM

No estimates available

Par Drugs & Chemicals Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

VOTE: Is Par Drugs & Chemicals Ltd. worth buying?

36 Votes:

Buy 80.56%

Sell 8.33%

Hold 11.11%

Par Drugs & Chemicals Live Share Price Today, Share Analysis and Chart

Par Drugs & Chemicals primarily engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets.

55.87% Fall from 52W High

SWOT Analysis

Par Drugs & Chemicals Live Price Chart